We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: A new study shows that a blood test estimating the biological age of 11 organ systems can forecast organ-specific disease and mortality risk years in advance (Image Credit: Shutterstock)

New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

A new blood proteomic test estimates biological ages of 11 organs and forecasts organ-specific disease and mortality years ahead. More...
16 Jun 2026
Image: DCISionRT integrates molecular biomarkers with clinicopathologic factors to assess individualized recurrence risk and predict radiation therapy benefit after breast-conserving surgery (Photo courtesy of PreludeDx)

Genomic Assay Predicts Recurrence Risk in Noninvasive Breast Cancer

A new genomic test integrates biomarkers and clinical data to stratify DCIS recurrence risk and predict radiation benefit. More...
16 Jun 2026
Image: Professor Alexander Hoischen using long read genome sequencing (Photo courtesy of Radboudumc)

Long-Read DNA Test Improves Diagnosis of Rare Genetic Diseases

A long-read genome sequencing test increases rare disease diagnoses and replaces 15 other tests. More...
15 Jun 2026
Image: Following FDA clearance, providers can prescribe the kit, enabling labs to process home-collected urine specimens on cobas automated platforms (Photo courtesy of Orasure Technologies)

At-Home Urine Collection Kit Enables High-Throughput STI Screening

OraSure Technologies’ Colli-Pee Dx Urine Collection Kit has received U.S. FDA clearance for use with Roche assays on the cobas molecular diagnostic system More...
15 Jun 2026
Image: Using deep sequencing of cell-free fetal DNA from maternal blood and advanced computational analysis, the method reconstructs fetal variants across the exome (Image credit: Adobe Stock)

Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening

A new noninvasive fetal sequencing method detects more than 95% of clinically relevant variants found by invasive genome sequencing. More...
15 Jun 2026
Image: Guardant360 CDx is approved as a companion diagnostic for therapies in NSCLC, breast cancer, and colorectal cancer (Photo courtesy of Guardant Health)

Blood-Based Assay Detects HER2 Mutations to Guide NSCLC Treatment

Guardant Health’s Guardant360 CDx has received FDA approval as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS. More...
15 Jun 2026
Image: By directly measuring circulating tumor-derived HPV DNA, the assay aims to identify postsurgical patients with persistent disease who may benefit from additional treatment (Image credit: iStock)

Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer

An ultrasensitive HPV blood assay detects tumor HPV DNA to flag residual head and neck cancer and predicts relapse months sooner. More...
12 Jun 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Immunofluorescence Analyzer
IFA System


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.